Seres Therapeutics, Inc. Common Stock (NASDAQ: MCRB) last traded at $4.56, down 0.22% on the session. The quote above updates while this page is open; the figures below are drawn from Seres Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Seres Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MCRB. Its market capitalisation is $45.33 million.
Valuation measures for Seres Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $45.33M |
|---|---|
| Enterprise value | $96.79M |
| Price / sales | 24.07 |
| Price / book | 1.31 |
| Beta | 1.08 |
Trailing-twelve-month figures tagged in Seres Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.88M |
|---|---|
| Net income (TTM) | -$22.46M |
| EPS (TTM) | -$2.45 |
| Operating margin | -4462.77% |
| Return on equity | -65.05% |
| Cash | $15.59M |
Range and volume for MCRB over the past 52 weeks.
| 52-week high | $29.98 |
|---|---|
| 52-week low | $4.32 |
| Volume | 45.2K |
| Average volume | 90.5K |
| Previous close | $4.57 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.